InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（18 笔）
内部人交易记录
首席执行官已披露买入
2
已披露卖出
18
T+90 胜率
50%
T+90 平均收益
-1.1%
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the detailed record of transactions filed by Chacko Jacob, 董事长兼首席执行官. Director active across 3 companies, notably Oric Pharmaceuticals, Inc.. In total, 26 filings have been logged. Breakdown: 2 buys · 18 sells. Total volume traded: €5.7m. History available since 11 May 2021. The latest transaction was disclosed on 15 December 2025 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Chacko Jacob
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报26 总计
83,666 股0Common StockSEC:0001608936-25-000014:0
37,461 股@ US$12.327.0% 占其流量Common StockSEC:0001608936-25-000010:0
34,538 股@ US$12.00856.8% 占其流量Common StockSEC:0001608936-25-000008:0
125,000 股@ US$10.799523.5% 占其流量Common StockSEC:0001608936-25-000006:0
67,000 股0Common StockSEC:0001415889-24-029631:0
40,000 股@ US$16.209513.6% 占其流量Common StockSEC:0001415889-24-007345:0
13,958 股@ US$12.11923.6% 占其流量Common StockSEC:0001415889-24-003114:0
38,667 股0Common StockSEC:0001209191-23-059263:0
10,508 股@ US$8.01411.7% 占其流量Common StockSEC:0001209191-23-042054:0
5,156 股@ US$8.00760.9% 占其流量Common StockSEC:0001209191-23-042054:1
4,336 股@ US$8.00520.7% 占其流量Common StockSEC:0001209191-23-041805:0
20,000 股@ US$8.02813.4% 占其流量Common StockSEC:0001209191-23-040090:0
5,000 股@ US$9.4131.9% 占其流量Common StockSEC:0001140361-23-020315:0
5,000 股@ US$20.053968.1% 占其流量Common StockSEC:0001140361-23-020315:1
6,137 股@ US$3.0730.4% 占其流量Common StockSEC:0001209191-23-010607:0
16,666 股0Common StockSEC:0001209191-22-061754:0
304,574 股@ US$2.9010.100% mcap25.4% 占其流量Common StockSEC:0001209191-22-028963:0
标准退出：2022年8月9日 (T+90)
257,127 股@ US$4.98150.14% mcap35.0% 占其流量Common StockSEC:0001209191-22-021153:0
标准退出：2022年6月21日 (T+90)
4,420 股@ US$25.04671.7% 占其流量Common StockSEC:0001209191-21-056460:0
2,942 股@ US$25.07931.1% 占其流量Common StockSEC:0001209191-21-055866:0
5,981 股@ US$25.10842.3% 占其流量Common StockSEC:0001209191-21-055291:0
400 股@ US$25.070.1% 占其流量Common StockSEC:0001209191-21-036686:0
2,468 股@ US$25.06640.9% 占其流量Common StockSEC:0001209191-21-035523:0
13,896 股@ US$25.36455.2% 占其流量Common StockSEC:0001209191-21-033813:0
1,090 股@ US$25.21980.4% 占其流量Common StockSEC:0001209191-21-032508:0
26 条申报中的 25 条
About Chacko Jacob
Chacko Jacob is President and CEO and has made 26 filings in total. Across the 26 sampled filings, the transactions span 2016-01-11 to 2025-12-17, with EUR 2001791 of buys and EUR 3704629 of sells, and the most common transaction nature is Sale. The filings cited concern Oric Pharmaceuticals, Inc.
